Home ›
Trademark Categories ›
Pharmaceuticals ›
2010 ›
TH ›
THERAFLU MAX-D
Trademark search for:
THERAFLU MAX-D
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2010-01-21 — Application filed
2010-01-25 — Application filed
2010-01-26 — Application filed
2010-03-19 — Assigned to examiner
2010-03-27 — Final disposition recorded
2010-03-27 — Final disposition recorded
2010-03-27 — Final disposition recorded
2010-03-30 — Office action issued
2010-04-09 — Teas/email correspondence entered
2010-04-09 — Assigned to lie
2010-04-09 — Correspondence received in law office
2010-05-19 — Approved for pub - principal register
2010-05-20 — Law office publication review completed
2010-06-22 — Published for opposition
2010-06-22 — Official gazette publication confirmation e-mailed
2010-08-17 — Noa e-mailed - sou required from applicant
2011-02-09 — Teas statement of use received
2011-02-09 — Use amendment filed
2011-03-01 — Case assigned to intent to use paralegal
2011-03-01 — Statement of use processing complete
2011-04-09 — Allowed principal register - sou accepted
2011-04-13 — Law office registration review completed
2011-04-14 — Notice of acceptance of statement of use e-mailed
2011-05-17 — Registered-principal register
2015-12-02 — Attorney/dom.rep.revoked and/or appointed
2015-12-02 — Teas revoke/app/change addr of atty/dom rep received
2015-12-09 — Automatic update of assignment of ownership
2016-05-17 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2017-12-22 — Cancelled sec. 8 (6-yr)
2017-12-22 — Final status recorded
Owner Information
NOVARTIS CONSUMER HEALTH S.A.
1197 PRANGINS CH
Novartis AG
Basel CH
Novartis AG
Basel CH
Novartis AG
Basel CH
Correspondent
Charles M. Atkinson GlaxoSmithKline 5 Crescent Drive LGTM - NY0300 Philadelphia, PA 19112
Filing Details
Filing Date:
2010-01-21
Status Date:
2017-12-22
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.